111 related articles for article (PubMed ID: 24522036)
1. Re: variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty.
Penson DF
J Urol; 2014 Mar; 191(3):658. PubMed ID: 24522036
[No Abstract] [Full Text] [Related]
2. Editorial comment.
Resnick MJ
Urology; 2013 Oct; 82(4):812-3. PubMed ID: 23910091
[No Abstract] [Full Text] [Related]
3. Management of prostate cancer patients following radiation therapy after radical surgery referred from urology to radiation oncology departments in Spain.
Gómez Caamaño A; Zapatero A; López Torrecilla J; Maldonado X
Clin Transl Oncol; 2016 Sep; 18(9):884-92. PubMed ID: 26621508
[TBL] [Abstract][Full Text] [Related]
4. Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty.
Kim SP; Tilburt JC; Karnes RJ; Ziegenfuss JY; Han LC; Shah ND; Frank I; Smaldone MC; Gross CP; Yu JB; Trinh QD; Sun M; O'Malley RL; Nguyen PL
Urology; 2013 Oct; 82(4):807-12. PubMed ID: 23910088
[TBL] [Abstract][Full Text] [Related]
5. Two Specialists, Two Recommendations: Discordance Between Urologists' & Radiation Oncologists' Prostate Cancer Treatment Recommendations.
Delaney RK; Sisco-Taylor BL; Wang X; Scherr K; Ubel PA; Haaland B; Kahn VC; Hamstra D; Wei JT; Madanay F; Davis JK; Greeno TU; Fagerlin A
Urology; 2022 Nov; 169():156-161. PubMed ID: 35768027
[TBL] [Abstract][Full Text] [Related]
6. The prostate cancer treatment bazaar: comment on "Physician visits prior to treatment for clinically localized prostate cancer".
Barry MJ
Arch Intern Med; 2010 Mar; 170(5):450-2. PubMed ID: 20212181
[No Abstract] [Full Text] [Related]
7. Impact of a Genomic Classifier of Metastatic Risk on Postprostatectomy Treatment Recommendations by Radiation Oncologists and Urologists.
Nguyen PL; Shin H; Yousefi K; Thompson DJ; Hornberger J; Hyatt AS; Badani KK; Morgan TM; Feng FY
Urology; 2015 Jul; 86(1):35-40. PubMed ID: 26142578
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy and surgery for high-risk localized prostate cancer: a UK questionnaire survey of urologists and clinical oncologists.
Gnanapragasam VJ; Persad R; Payne HA
BJU Int; 2012 Sep; 110(5):608-12. PubMed ID: 22765394
[No Abstract] [Full Text] [Related]
9. Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey.
Ariane MM; Ploussard G; Rebillard X; Malavaud B; Rischmann P; Hennequin C; Mongiat-Artus P
World J Urol; 2015 Nov; 33(11):1741-7. PubMed ID: 25822706
[TBL] [Abstract][Full Text] [Related]
10. US urology clinics overprescribe prostate radiotherapy.
Furlow B
Lancet Oncol; 2011 Feb; 12(2):122. PubMed ID: 21355130
[No Abstract] [Full Text] [Related]
11. Introduction.
Efstathiou JA
Semin Radiat Oncol; 2017 Jan; 27(1):1-2. PubMed ID: 27986206
[No Abstract] [Full Text] [Related]
12. Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer.
Kim SP; Gross CP; Nguyen PL; Smaldone MC; Thompson RH; Shah ND; Kutikov A; Han LC; Karnes RJ; Ziegenfuss JY; Tilburt JC
Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):163-9. PubMed ID: 24566445
[TBL] [Abstract][Full Text] [Related]
13. Knowledge, attitudes and beliefs towards management of men with locally advanced prostate cancer following radical prostatectomy: an Australian survey of urologists.
Brown B; Young J; Kneebone AB; Brooks AJ; Dominello A; Haines M
BJU Int; 2016 Apr; 117 Suppl 4():35-44. PubMed ID: 25585989
[TBL] [Abstract][Full Text] [Related]
14. Image Guided Radiation Therapy (IGRT) Practice Patterns and IGRT's Impact on Workflow and Treatment Planning: Results From a National Survey of American Society for Radiation Oncology Members.
Nabavizadeh N; Elliott DA; Chen Y; Kusano AS; Mitin T; Thomas CR; Holland JM
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):850-7. PubMed ID: 26972658
[TBL] [Abstract][Full Text] [Related]
15. Multiple physician recommendations for prostate cancer treatment: a Pandora's box for patients?
Underwood W; Orom H; Poch M; West BT; Lantz PM; Chang SS; Fowke JH
Can J Urol; 2010 Oct; 17(5):5346-54. PubMed ID: 20974025
[TBL] [Abstract][Full Text] [Related]
16. Practice- vs Physician-Level Variation in Use of Active Surveillance for Men With Low-Risk Prostate Cancer: Implications for Collaborative Quality Improvement.
Auffenberg GB; Lane BR; Linsell S; Cher ML; Miller DC
JAMA Surg; 2017 Oct; 152(10):978-980. PubMed ID: 28636713
[TBL] [Abstract][Full Text] [Related]
17. Formation of combined urology and radiation oncology practices: objective data from radiation oncologists for rationale.
Schilling PJ
Am J Clin Oncol; 2011 Jun; 34(3):289-91. PubMed ID: 20805740
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the French practices in brachytherapy using surveys].
Delattre B; Cormier L; Borgogno C; Descotes JL; Peiffert D; Hannoun-Levi JM; Moreau JL
Prog Urol; 2017 Oct; 27(12):626-631. PubMed ID: 28651992
[TBL] [Abstract][Full Text] [Related]
19. Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice.
Panje CM; Dal Pra A; Zilli T; R Zwahlen D; Papachristofilou A; Herrera FG; Matzinger O; Plasswilm L; Putora PM
Strahlenther Onkol; 2015 Oct; 191(10):778-86. PubMed ID: 25986251
[TBL] [Abstract][Full Text] [Related]
20. Point/Counterpoint. Proton therapy is the best radiation treatment modality for prostate cancer.
Moyers MF; Pouliot J; Orton CG
Med Phys; 2007 Feb; 34(2):375-8. PubMed ID: 17388153
[No Abstract] [Full Text] [Related]
[Next] [New Search]
